Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yantai Lundy Biotechnology is a specialized developer and manufacturer of in vitro diagnostic (IVD) reagents and instruments, primarily focusing on point-of-care testing (POCT). The company utilizes advanced immunochromatography technologies, including colloidal gold and fluorescence platforms, to provide rapid diagnostic solutions for clinical use. Their extensive product portfolio includes tests for cardiac markers, inflammatory indicators, coagulation, and infectious diseases, supported by proprietary automated analyzers. Based in Yantai, China, the company operates within a GMP-compliant infrastructure and serves a broad network of healthcare providers. Lundy Biotechnology is committed to enhancing diagnostic efficiency through continuous innovation in biosensor and reagent technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yantai Lundy Biotechnology.